22.692 articles found

Melatonin and aging: prospects for human treatment.

Bubenik GA, Konturek SJ.

J Physiol Pharmacol · 2011-02-01

PMID: 21451205

Development of a speech treatment program for a client with essential vocal tremor.

Barkmeier-Kraemer J, Lato A, Wiley K.

Semin Speech Lang · 2011-02-01

DOI: 10.1055/s-0031-1271974PMID: 21491358

[Dementia in Parkinson's disease: risk factors, diagnosis and treatment].

Bakay S, Bechet S, Barjona A, Delvaux V, Salmon E, Garraux G.

Rev Med Liege · 2011-02-01

PMID: 21661202

Electroconvulsive treatment of a patient with Parkinson's disease and moderate depression.

Berg JE.

Ment Illn · 2011-02-01

DOI: 10.4081/mi.2011.e3PMID: 25478095

Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.

Marras C, McDermott MP, Marek K, Rochon P, Naglie G, Tanner CM, Rudolph A, Shoulson I, Lang AE, Parkinson Study Group DATATOP and PRECEPT investigators.

Mov Disord · 2011-02-01

DOI: 10.1002/mds.23581PMID: 21287602

Does neurotrophic factor benefit to PD therapy via co-function with ubiquitin-proteasome system?

Niu C, Zhang J, Mei J, Fu X.

Med Hypotheses · 2011-02-01

DOI: 10.1016/j.mehy.2011.01.007PMID: 21288653

Hepcidin treatment modulates the expression of divalent metal transporter-1, ceruloplasmin, and ferroportin-1 in the rat cerebral cortex and hippocampus.

Li L, Holscher C, Chen BB, Zhang ZF, Liu YZ.

Biol Trace Elem Res · 2011-01-28

DOI: 10.1007/s12011-011-8967-3PMID: 21274654

Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse.

Zhou QH, Hui EK, Lu JZ, Boado RJ, Pardridge WM.

Brain Res · 2011-01-26

DOI: 10.1016/j.brainres.2011.01.061PMID: 21276430

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATONS

CHOBANIAN HARRY, LIN LINUS S, LIU PING, CHIODA MARC D, DEVITA ROBERT J, NARGUND RAVI P, GUO YAN, HAMILL TERENCE, LI WENPING, HENZE DARRELL A.

· 2011-01-25

Levodopa enhances reward learning but impairs reversal learning in Parkinson's disease patients.

Moustafa AA.

Front Hum Neurosci · 2011-01-25

DOI: 10.3389/fnhum.2010.00240PMID: 21289872

Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson's disease dementia.

Ho YJ, Ho SC, Pawlak CR, Yeh KY.

Behav Brain Res · 2011-01-22

DOI: 10.1016/j.bbr.2011.01.028PMID: 21262271

Levodopa effect on electromyographic activation patterns of tibialis anterior muscle during walking in Parkinson's disease.

Caliandro P, Ferrarin M, Cioni M, Bentivoglio AR, Minciotti I, D'Urso PI, Tonali PA, Padua L.

Gait Posture · 2011-01-21

DOI: 10.1016/j.gaitpost.2010.12.020PMID: 21256751